Journal of Vaccines and Immunology,
Journal Year:
2023,
Volume and Issue:
10(1), P. 001 - 005
Published: Feb. 8, 2023
The
COVID-19
pandemic
of
2020
shook
the
world
with
its
unprecedented
scale,
affecting
over
700
million
people
and
causing
nearly
7
deaths
globally.
In
response,
rapid
extraordinary
measures
were
taken,
including
development
distribution
vaccines
at
an
pace.
However,
speed
magnitude
response
have
raised
questions
about
efficacy
ethics
certain
measures.
To
address
these
concerns,
we
present
a
non-comprehensive
list
contentious
issues
that
merit
discussion
investigation
by
scientific
medical
communities.
These
encompass
public
education,
ethical
considerations,
legal
implications,
policy
decisions,
regulatory
oversight,
gaps
in
knowledge,
concerns
related
to
mass
vaccination
efforts.
By
examining
topics,
aim
improve
future
crisis
responses
maintain
trust
participation
programs.
It
is
essential
learn
from
successes
shortcomings
better
prepare
for
health
crises
ensure
safety
well-being
communities
worldwide.
IJID Regions,
Journal Year:
2024,
Volume and Issue:
14, P. 100500 - 100500
Published: Nov. 27, 2024
The
overall
impact
of
the
COVID-19
pandemic
on
mortality
can
be
estimated
by
assessment
excess
deaths
from
all
causes
because
reported
number
due
to
do
not
accurately
reflect
true
death
toll.
We
assessed
in
2020
and
2021
Netherlands.
All
analyses
were
performed
data
comprehensive
nationwide
registers
provided
Statistics
Netherlands
(Centraal
Bureau
voor
de
Statistiek),
including
demographic
characteristics
mortality.
All-cause
incidence
rates
calculated
per
calendar
month
compared
against
infections
preventive
strategies.
all-cause
rate
ratios
(IRRs)
with
95%
confidence
intervals
(95%
CIs)
year
using
Poisson
regression
(overall
for
subgroups).
Compared
predicted
based
2019
rates,
was
8.9%
(IRR
1.089,
CI
1.081-1.097)
8.5%
1.085,
1.077-1.092)
2021.
Relative
higher
men,
people
low
household
income,
first-generation
immigrants,
individuals
living
extremely
urbanized
areas.
In
2020,
highest
age
groups
above
75
years
(over
10%.);
2021,
it
clearly
present
even
20-39
group
(6.6%).
Our
results
quantify
during
first
2
show
that
extent
varies
considerably
across
groups,
which
may
help
identifying
target
strategies
future
health
crises.
International Journal of Epidemiology,
Journal Year:
2024,
Volume and Issue:
54(1)
Published: Dec. 16, 2024
Abstract
Background
During
the
COVID-19
pandemic,
mortality
from
some
chronic
diseases
increased.
In
this
study,
we
evaluated
monthly
excess
all
causes,
cancer,
cardiovascular
(CVD)
and
diabetes
during
months
of
2020
2021,
examining
its
relationship
with
cases.
Methods
Monthly
cause-specific
data
were
downloaded
public
repositories
national
statistics
offices
or
directly
requested
them,
population
obtained
United
Nations
archives.
Excess
deaths
estimated
as
difference
between
observed
expected
deaths.
for
2021
calculated
using
a
quasi-Poisson
regression
model
trained
on
2010–19
(or
shorter
timespan
if
full
decade
was
not
available).
To
quantify
correlation
cases
mortality,
used
Spearman’s
coefficient
(rs).
Results
The
study
included
16
countries
that
provided
causes
death
(Argentina,
Austria,
Brazil,
Switzerland,
Chile,
Czech
Republic,
Germany,
Georgia,
Hungary,
Italy,
Lithuania,
Latvia,
Mexico,
Serbia,
Slovakia
USA).
A
positive
found
in
(rs
ranging
0.61
to
0.91),
CVD
11
0.45
0.85)
13
0.42
0.79).
above
5%
14
both
seven
nine
12
2021.
No
cancer
any
considered.
Conclusions
persisted
several
throughout
These
increases
coincide
peaks,
supporting
short-term
impact
pandemic
these
causes.
A
recent
publication
defined
lockdown
“revisionism”
as
“the
spread
of
misinformation
on
lockdowns
and
other
public
health
measures.”
We
used
this
to
analyze
the
claim
that
questioning
or
interventions
mandates
amounts
“misinformation”.
suggest
term
‘revisionism’,
like
‘misinformation’
contained
in
its
definition,
were
merely
labels
denigrate
evidence-based
contrary
conclusions
so
avoid
having
critically
appraise
best
evidence
itself.
aim
describe
how,
by
glossing
over
topics
without
fully
engaging
with
available,
assertions
made
do
not
withstand
critical
scrutiny.
that,
ensure
lessons
are
learned
for
future,
we
must
be
willing
engage
rigorous
open
debate
–
calling
reasonable
scrutiny
‘misinformation’,
‘disinformation’,
‘revisionism’
is
supportive
goal.
Finally,
a
main
lesson
from
COVID-19
pandemic
have
an
increased
focus
so-called
but
rather
re-discover
emergency
management
process
making
decisions
multidisciplinary
representation,
transparency,
cost-benefit
analyses
courses
using
protects
against
censorship
groupthink.
Journal of Vaccines and Immunology,
Journal Year:
2023,
Volume and Issue:
10(1), P. 001 - 005
Published: Feb. 8, 2023
The
COVID-19
pandemic
of
2020
shook
the
world
with
its
unprecedented
scale,
affecting
over
700
million
people
and
causing
nearly
7
deaths
globally.
In
response,
rapid
extraordinary
measures
were
taken,
including
development
distribution
vaccines
at
an
pace.
However,
speed
magnitude
response
have
raised
questions
about
efficacy
ethics
certain
measures.
To
address
these
concerns,
we
present
a
non-comprehensive
list
contentious
issues
that
merit
discussion
investigation
by
scientific
medical
communities.
These
encompass
public
education,
ethical
considerations,
legal
implications,
policy
decisions,
regulatory
oversight,
gaps
in
knowledge,
concerns
related
to
mass
vaccination
efforts.
By
examining
topics,
aim
improve
future
crisis
responses
maintain
trust
participation
programs.
It
is
essential
learn
from
successes
shortcomings
better
prepare
for
health
crises
ensure
safety
well-being
communities
worldwide.